Supportive care needs of patients living with an extremely rare and unpredictable cancer: The Epithelioid Haemangioendothelioma patient experience

Olga Husson*, Marije Weidema, Hugh Leonard, Lisa Hartle Deyoung, Winette Graaf, Lonneke van de Poll‐Franse

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

68 Downloads (Pure)

Abstract

Objective
Epithelioid haemangioendothelioma (EHE) is an ultrarare vascular sarcoma with an incidence of <1/million/year and a large clinical heterogeneity. Data on supportive care needs of rare cancer patients are scarce. This study aimed to investigate the level of supportive care needs of EHE patients and its association with sociodemographic, clinical and symptom burden characteristics.

Methods
We present secondary data of a cross-sectional questionnaire study involving EHE patients recruited from the international EHE Facebook group. Data were collected using the web-based PROFILES registry. Unmet needs were measured with Supportive Care Needs Survey Short Form (SCNS-SF34).

Results
115 EHE patients from 20 countries completed the online questionnaire. Mean level of supportive care needs was 68.4 (range 34–170), with the highest mean score on the psychological domain. Supportive care needs were associated with age, disease stage, years since diagnosis and number of tumour locations. Highly symptomatic patients (33%) reported more supportive care needs than patients with low or intermediate symptom burden.

Conclusion
Supportive care needs were found in all domains, highest in the psychological domain, and were associated with sociodemographic, clinical and symptom burden characteristics. Adequate and tailored supportive care should be offered especially to highly symptomatic EHE patients.
Original languageEnglish
Article numbere13461
JournalEuropean Journal of Cancer Care
Volume30
Issue number6
DOIs
Publication statusPublished - 2021

Fingerprint

Dive into the research topics of 'Supportive care needs of patients living with an extremely rare and unpredictable cancer: The Epithelioid Haemangioendothelioma patient experience'. Together they form a unique fingerprint.

Cite this